A retrospective angiography study in T2DM suggests that pairing a stress-glycemia index (SHR) with an inflammation index (SIRI) improves CHD risk stratification compared with using either marker alone. Why CHD is a high-stakes problem in […]
Meta-analysis highlights long-term advantages in type 2 diabetes treatment Type 2 diabetes mellitus (T2DM) is a chronic disease marked by insulin resistance and progressive β-cell decline. As the condition advances, many patients experience rising blood […]
Peer review is an essential part of the scientific publishing process, helping to ensure that research papers meet high standards of quality and accuracy. Each month, the BiomolBiomed Editorial team recognizes a reviewer who has gone above […]
Type 2 diabetes (T2D) is the fastest growing health problem worldwide. Due to the development of modern technologies, a significant progress has been made in the last decade to understand the role of genetics in […]
Diabetic nephropathy (DN) is a complication of diabetes mellitus, that affects the kidneys and can severely worsen the quality of life. Many studies have shown that inflammation is one of the mechanisms involved in the […]
Numerous studies have shown that patients with type-2 diabetes mellitus (T2DM) and atherosclerosis are subject to chronic, mild, subclinical inflammation. Furthermore, these studies have shown the that inflammation plays an important role in the development […]
Recent studies point to significant role of endothelial dysfunction in the pathogenesis of type 2 diabetes mellitus and its complications. However, an investigation of an association between asymmetric dimethylarginine (ADMA), as a novel marker of […]
Copyright (c) 2021 Association of Basic Medical Sciences of FBIH